Kliničke studije za Гојазност u državi Florida
80 studija za Гојазност traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
- Orlando33 студија
- Miami28 студија
- Jacksonville25 студија
- Deltona14 студија
- Hialeah13 студија
- Pembroke Pines10 студија
- St. Petersburg9 студија
- Tampa9 студија
- The Villages9 студија
- Ocala8 студија
- West Palm Beach8 студија
- Clearwater7 студија
- Doral7 студија
- Boca Raton7 студија
- Davie7 студија
- Town 'n' Country6 студија
- Kendall6 студија
- Tallahassee6 студија
- Pensacola6 студија
- Miramar5 студија
- Hollywood5 студија
- Leesburg4 студија
- Spring Hill4 студија
- Naples4 студија
- Cape Coral3 студија
- Palm Coast3 студија
Zvanični tekst studije (na engleskom)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Southern Clinical Research, Miami
- Research Institute of South Florida, Miami
- Clinical Neuroscience Solutions LLC, Orlando
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Alliance for Multispecialty Research (AMR) Clinical Miami, Doral
- AMR Clinical - Fort Myers, Fort Myers
- AGA Clinical Trials, Hialeah
- и још 6
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- University of Florida Department of Medicine, Gainesville
- Aga Clinical Trials, Hialeah
- South Florida Clinical Research, Margate
- и још 7
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Westside Center for Clinical Research, Jacksonville
- Jacksonville Center for Clinical Research, Jacksonville
- Suncoast Clinical Research, New Port Richey
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07845500Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Bioclinical Research Alliance, Miami
- Indago Research and Health Center, Miami Lakes
- Clinical Research Center Of Florida, Pompano Beach
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Suncoast Clinical Research, New Port Richey
- Progressive Medical Research, Port Orange
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07843498A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Clinical Research of West Florida, Inc., Clearwater
- Universal Axon Clinical Research LLC, Doral
- Westside Center for Clinical Research, Jacksonville
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Med Research of Florida, LLC, Miami
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07854782A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- American Research Centers of Florida, Pembroke Pines
- Encore Medical Research - Weston, Weston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- NeoClinical Research, Hialeah
- Skin Care Research, Hollywood
- Encore Medical Research, Hollywood
- и још 2
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- All Childrens Hospital, St. Petersburg
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- JEM Research Institute, Atlantis
- AMR Clinical, Doral
- Northeast Research Institute (NERI), Fleming Island
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Westside Center for Clinical Research, Jacksonville
- Care Access - St. Petersburg, St. Petersburg
- Conquest Research, Winter Park
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- и још 3
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
- Emerald Coast Neurology - Airport Boulevard, Pensacola
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- и још 3
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- International Research Associates LLC, Miami
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07915609A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- All Childrens Hospital, St. Petersburg
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Omega Research Orlando, Altamonte Springs
- American Research Institute, Cutler Bay
- K2 Medical Research - Maitland, Maitland
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Fortrea Clinical Research Unit - Daytona Beach, Daytona Beach
- AGA Clinical Trials, Hialeah
- K2 Medical Research Orlando, Maitland
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 2. 11. 2026. · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Clearwater
- Research Site, Jacksonville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Orlando Heart and Vascular Institute, Altamonte Springs
- D and H Tamarac Research Center, Aventura
- Excel Medical Clinical Trials, Boca Raton
- и још 18
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Doral
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Innovative Research of West Florida /ID# 281963, Clearwater
- Northeast Research Institute (NERI) /ID# 282015, Fleming Island
- Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
- и још 10
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Bradenton
- DM Clinical Research, Doral
- Clinical Neuroscience Solutions, Orlando
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight
- Ascletis Clinical Site, South Miami
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 10. 2026. · NCT07893106A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Clearwater
- ACCOMPLISH-2 Research Site, Fort Myers
- ACCOMPLISH-2 Research Site, Jacksonville
- и још 5
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Northeast Research Institute, Fleming Island
- Jacksonville Ctr For Clin Res, Jacksonville
- Center for Diab,Obes & Metab, Pembroke Pines
- и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07607587Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 50 до 95 · Оба пола · Ажурирано 15. 10. 2026. · NCT06604650The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Imagine Research, Boynton Beach
- HCA Health Research Institute, Miami
- UMiami, Miami
- и још 6
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Fortrea Clinical Research Unit, Daytona Beach
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 8. 10. 2026. · NCT07808073A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
- Fortrea Clinical Research Unit, Daytona Beach
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 60 · Жене · Ажурирано 8. 10. 2026. · NCT07808060Breathing & Blood Pressure
- Florida State University, Tallahassee
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 45 · Оба пола · Ажурирано 7. 10. 2026. · NCT05632406Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.